- Senior Researcher of VHIO´s Genitourinary, Central Nervous System (CNS) Tumors, Sarcoma and Cancer of Unknown Primary Site Group
Dr. Suárez received her M.D in Medicine and Surgery at the Autonomous University of Barcelona. She gets a Specialist Training, Medical Oncology at the Faculty of Medicine, Autonomous University of Barcelona. “Hospital del Mar – Parc de la Salut” of Barcelona.
In 2008, she joined the Oncology Department of Vall d’Hebron University Hospital as Physician (attending staff), of the Genitourinary, Central Nervous System, Sarcoma and Tumors of Unknown Origin Program.
In 2018 obtained “Cum Laude” qualification when she completes her studies of doctorate with the doctoral thesis: “Prognostic value of genetic alterations in the mTOR pathway of patients with metastatic renal cell carcinoma treated with mTOR inhibitors”.
Dr. Suárez has been co-investigator and principal investigator in several clinical trials related with genitourinary malignancies from 2008 ongoing. She is also Author and Co-Author of more than 100 scientific papers, posters and book chapters national and international, especially focused in the area of genitourinary tumors.
She is Vice President of SOGUG (Spanish Oncology Genito Urinary Group), active member of several oncology societies like ASCO, ESMO, SEOM, SOGUG), Scientific committee member of American Society of Clinical Oncology (ASCO) and European Society of Medical Oncology (ESMO).